Published in Arterioscler Thromb Vasc Biol on May 24, 2012
Endothelial Nlrp3 inflammasome activation associated with lysosomal destabilization during coronary arteritis. Biochim Biophys Acta (2014) 0.87
Vascular health late after Kawasaki disease: implications for accelerated atherosclerosis. Korean J Pediatr (2014) 0.78
Kawasaki disease: a matter of innate immunity. Clin Exp Immunol (2016) 0.77
Histopathological Characteristics of Post-inflamed Coronary Arteries in Kawasaki Disease-like Vasculitis of Rabbits. Acta Histochem Cytochem (2016) 0.75
Anti-atherosclerotic effect of traditional fermented cheese whey in atherosclerotic rabbits and identification of probiotics. BMC Complement Altern Med (2016) 0.75
Reassessment of carotid intima-media thickness by standard deviation score in children and adolescents after Kawasaki disease. Springerplus (2015) 0.75
Clinical relevance of gemstone spectral CT in the diagnosis of carotid atherosclerosis. Exp Ther Med (2017) 0.75
Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med (2005) 28.21
Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell (2001) 13.24
Dendritic cells: specialized and regulated antigen processing machines. Cell (2001) 10.44
A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics (1974) 9.97
The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol (2006) 9.61
Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med (2003) 7.86
Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation (1996) 7.29
Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci U S A (2004) 5.58
Innate and acquired immunity in atherogenesis. Nat Med (2002) 4.22
Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res (2002) 3.69
The yin and yang of type I interferon activity in bacterial infection. Nat Rev Immunol (2005) 3.65
The inflammasomes: mechanisms of activation and function. Curr Opin Immunol (2010) 3.41
Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol (2003) 3.18
Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol (2001) 2.89
Toll-dependent control mechanisms of CD4 T cell activation. Immunity (2004) 2.88
Sensing pathogens and tuning immune responses. Science (2001) 2.73
Autoimmune and inflammatory mechanisms in atherosclerosis. Annu Rev Immunol (2004) 2.59
High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study. Arthritis Rheum (2008) 2.14
Pathology of the heart in Kawasaki disease. Pediatrics (1978) 2.10
Innate immunity, macrophage activation, and atherosclerosis. Immunol Rev (2007) 1.94
When children with Kawasaki disease grow up: Myocardial and vascular complications in adulthood. J Am Coll Cardiol (2009) 1.88
Anakinra for rheumatoid arthritis: a systematic review. J Rheumatol (2009) 1.82
Pathogen-sensing plasmacytoid dendritic cells stimulate cytotoxic T-cell function in the atherosclerotic plaque through interferon-alpha. Circulation (2006) 1.77
Interleukin-1β is crucial for the induction of coronary artery inflammation in a mouse model of Kawasaki disease. Circulation (2012) 1.70
Apolipoprotein E modulates clearance of apoptotic bodies in vitro and in vivo, resulting in a systemic proinflammatory state in apolipoprotein E-deficient mice. J Immunol (2004) 1.63
Interleukin-1beta and the autoinflammatory diseases. N Engl J Med (2009) 1.63
Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice. Cardiovasc Res (2005) 1.49
Apolipoprotein E induces antiinflammatory phenotype in macrophages. Arterioscler Thromb Vasc Biol (2011) 1.47
The role of IL-1 in the pathogenesis of heart disease. Arch Immunol Ther Exp (Warsz) (2009) 1.45
Rate and determinants of progression of atherosclerosis in systemic lupus erythematosus. Arthritis Rheum (2007) 1.43
IL-17A is proatherogenic in high-fat diet-induced and Chlamydia pneumoniae infection-accelerated atherosclerosis in mice. J Immunol (2010) 1.36
Functional profile of activated dendritic cells in unstable atherosclerotic plaque. Basic Res Cardiol (2006) 1.34
Are patients after Kawasaki disease at increased risk for accelerated atherosclerosis? J Pediatr (2007) 1.33
Subclinical atherosclerosis, but normal autonomic function after Kawasaki disease. J Pediatr (2007) 1.32
Dendritic cells at the host-pathogen interface. Nat Immunol (2002) 1.30
Interleukin-1beta and signaling of interleukin-1 in vascular wall and circulating cells modulates the extent of neointima formation in mice. Am J Pathol (2006) 1.30
Lack of interleukin-1 receptor antagonist modulates plaque composition in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol (2004) 1.28
TLR/MyD88 and liver X receptor alpha signaling pathways reciprocally control Chlamydia pneumoniae-induced acceleration of atherosclerosis. J Immunol (2008) 1.22
Altered lipid profile after Kawasaki syndrome. Circulation (1991) 1.19
Treatment of Kawasaki disease: analysis of 27 US pediatric hospitals from 2001 to 2006. Pediatrics (2009) 1.17
TLR2 and MyD88 contribute to Lactobacillus casei extract-induced focal coronary arteritis in a mouse model of Kawasaki disease. Circulation (2005) 1.14
Prevalence of traditional modifiable cardiovascular risk factors in patients with rheumatoid arthritis: comparison with control subjects from the multi-ethnic study of atherosclerosis. Semin Arthritis Rheum (2012) 1.10
Kawasaki Disease update. Indian J Pediatr (2009) 1.10
Coronary arteritis in mice following the systemic injection of group B Lactobacillus casei cell walls in aqueous suspension. Arthritis Rheum (1985) 1.09
Activated myeloid dendritic cells accumulate and co-localize with CD3+ T cells in coronary artery lesions in patients with Kawasaki disease. Exp Mol Pathol (2007) 1.08
Long-term outcome of Kawasaki disease. Circulation (2008) 1.08
Long-term prognosis of Kawasaki disease: increased cardiovascular risk? Curr Opin Pediatr (2010) 1.07
Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis. Arthritis Res Ther (2010) 0.98
Atherosclerotic cardiovascular disease beginning in childhood. Korean Circ J (2010) 0.92
Effects of statin therapy in children complicated with coronary arterial abnormality late after Kawasaki disease: a pilot study. Circ J (2008) 0.89
Atherosclerosis in survivors of Kawasaki disease. J Pediatr (2009) 0.89
In-vivo assessment of the natural history of coronary atherosclerosis: vascular remodeling and endothelial shear stress determine the complexity of atherosclerotic disease progression. Curr Opin Cardiol (2010) 0.88
Can we prevent long term cardiac damage in Kawasaki disease? Lessons from Lactobacillus casei cell wall-induced arteritis in mice. Clin Exp Rheumatol (1993) 0.85
Characteristics of earlier atherosclerotic involvement in adolescent patients with Kawasaki disease and coronary artery lesions: significance of gray scale median on B-mode ultrasound. Atherosclerosis (2012) 0.83
Are patients with Kawasaki disease at risk for premature atherosclerosis? J Pediatr (2007) 0.82
Animal models of vasculitis. Lessons we can learn to improve our understanding of Kawasaki disease. Rheum Dis Clin North Am (1988) 0.82
Management of myocardial infarction in children with Kawasaki disease. Blood Coagul Fibrinolysis (2010) 0.81
Frequency and size of coronary arterial aneurysm at necropsy in Kawasaki disease. Am J Cardiol (1987) 0.79
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation (2003) 8.61
Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med (2012) 7.93
Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci U S A (2004) 5.58
Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity (2012) 5.08
Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. Am J Physiol Gastrointest Liver Physiol (2005) 4.28
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation (2003) 3.94
From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report. Am J Cardiol (2006) 3.82
TLR signaling in the gut in health and disease. J Immunol (2005) 3.51
Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut. J Immunol (2003) 2.96
The roles of bacteria and TLR4 in rat and murine models of necrotizing enterocolitis. J Immunol (2006) 2.83
Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine. Gastroenterology (2006) 2.78
HMGB1 mediates endogenous TLR2 activation and brain tumor regression. PLoS Med (2009) 2.56
TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells. J Biol Chem (2002) 2.37
Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome. Am Heart J (2009) 2.21
Blood-brain barrier invasion by group B Streptococcus depends upon proper cell-surface anchoring of lipoteichoic acid. J Clin Invest (2005) 2.07
Beta-defensin-2 expression is regulated by TLR signaling in intestinal epithelial cells. J Immunol (2004) 2.05
The future of pediatric rheumatology: many questions remain. Arthritis Rheum (2007) 2.02
Differential effects of green tea-derived catechin on developing versus established atherosclerosis in apolipoprotein E-null mice. Circulation (2004) 1.94
Analysis of TLR4 polymorphic variants: new insights into TLR4/MD-2/CD14 stoichiometry, structure, and signaling. J Immunol (2006) 1.88
Calcification in atherosclerosis: bone biology and chronic inflammation at the arterial crossroads. Proc Natl Acad Sci U S A (2003) 1.87
Adenovirus. Semin Respir Crit Care Med (2011) 1.86
Opposing biological functions of tryptophan catabolizing enzymes during intracellular infection. J Infect Dis (2011) 1.86
Distinct mutations in IRAK-4 confer hyporesponsiveness to lipopolysaccharide and interleukin-1 in a patient with recurrent bacterial infections. J Exp Med (2003) 1.83
Molecular, endocrine, and genetic mechanisms of arterial calcification. Endocr Rev (2004) 1.83
Chlamydial heat shock protein 60 activates macrophages and endothelial cells through Toll-like receptor 4 and MD2 in a MyD88-dependent pathway. J Immunol (2002) 1.82
Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease. J Am Coll Cardiol (2006) 1.78
Recombinant antibodies to an oxidized low-density lipoprotein epitope induce rapid regression of atherosclerosis in apobec-1(-/-)/low-density lipoprotein receptor(-/-) mice. J Am Coll Cardiol (2007) 1.77
Homocysteine hypothesis for atherothrombotic cardiovascular disease: not validated. J Am Coll Cardiol (2006) 1.75
Staphylococcus aureus Panton-Valentine leukocidin contributes to inflammation and muscle tissue injury. PLoS One (2009) 1.74
Interleukin-1β is crucial for the induction of coronary artery inflammation in a mouse model of Kawasaki disease. Circulation (2012) 1.70
Screen testing cardiovascular prevention in asymptomatic diabetic patients. J Am Coll Cardiol (2007) 1.68
TLR signaling: an emerging bridge from innate immunity to atherogenesis. J Immunol (2004) 1.62
Inhibitory effect on arterial injury-induced neointimal formation by adoptive B-cell transfer in Rag-1 knockout mice. Arterioscler Thromb Vasc Biol (2002) 1.59
The NOD/RIP2 pathway is essential for host defenses against Chlamydophila pneumoniae lung infection. PLoS Pathog (2009) 1.58
Juvenile polyarteritis: results of a multicenter survey of 110 children. J Pediatr (2004) 1.57
Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells. Steroids (2005) 1.57
Age- and sex-related patterns of serum interferon-alpha activity in lupus families. Arthritis Rheum (2008) 1.53
Atorvastatin enhances interleukin-10 levels and improves cardiac function in rats after acute myocardial infarction. Clin Sci (Lond) (2009) 1.52
Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models. J Am Chem Soc (2014) 1.49
Serum levels of the Th1 chemoattractant interferon-gamma-inducible protein (IP) 10 are elevated in patients with essential hypertension. Hypertens Res (2011) 1.49
Comparison of coronary artery bypass surgery and percutaneous drug-eluting stent implantation for treatment of left main coronary artery stenosis. JACC Cardiovasc Interv (2008) 1.48
TLR signaling at the intestinal epithelial interface. J Endotoxin Res (2003) 1.47
MyD88 is pivotal for the early inflammatory response and subsequent bacterial clearance and survival in a mouse model of Chlamydia pneumoniae pneumonia. J Biol Chem (2005) 1.47
Transforming growth factor-beta differentially inhibits MyD88-dependent, but not TRAM- and TRIF-dependent, lipopolysaccharide-induced TLR4 signaling. J Biol Chem (2004) 1.46
Modulatory profiling identifies mechanisms of small molecule-induced cell death. Proc Natl Acad Sci U S A (2011) 1.45
Decrease in dendritic cells in endomyocardial biopsies of human dilated cardiomyopathy. Eur J Heart Fail (2013) 1.43
Comparison of drug-eluting stents with bare metal stents in unselected patients with acute myocardial infarction. Catheter Cardiovasc Interv (2007) 1.40
Intraoperative acquired pressure ulcer on lower lip: a complication of rhinoplasty. J Craniofac Surg (2014) 1.39
Presence and severity of noncalcified coronary plaque on 64-slice computed tomographic coronary angiography in patients with zero and low coronary artery calcium. Am J Cardiol (2007) 1.38
Immunohistochemical characterisation of vascular dendritic cells: puzzling the pitfalls. Pathology (2011) 1.38
Role of the Jak/STAT pathway in the regulation of interleukin-8 transcription by oxidized phospholipids in vitro and in atherosclerosis in vivo. J Biol Chem (2007) 1.37
Intravenous mesenchymal stem cell therapy early after reperfused acute myocardial infarction improves left ventricular function and alters electrophysiologic properties. Int J Cardiol (2005) 1.37
Physician-directed patient self-management of left atrial pressure in advanced chronic heart failure. Circulation (2010) 1.36
IL-17A is proatherogenic in high-fat diet-induced and Chlamydia pneumoniae infection-accelerated atherosclerosis in mice. J Immunol (2010) 1.36
Hydroxychloroquine cardiotoxicity in systemic lupus erythematosus: a report of 2 cases and review of the literature. Semin Arthritis Rheum (2004) 1.35
Differential effects of apolipoprotein A-I-mimetic peptide on evolving and established atherosclerosis in apolipoprotein E-null mice. Circulation (2004) 1.35
Mycobacterium tuberculosis heat shock proteins use diverse Toll-like receptor pathways to activate pro-inflammatory signals. J Biol Chem (2005) 1.34
Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice. Atherosclerosis (2006) 1.33
Connective tissue growth factor is overexpressed in complicated atherosclerotic plaques and induces mononuclear cell chemotaxis in vitro. Arterioscler Thromb Vasc Biol (2005) 1.32
Innate immunity and toll-like receptors: clinical implications of basic science research. J Pediatr (2004) 1.28
Toll-like receptor 2 signaling protects mice from tumor development in a mouse model of colitis-induced cancer. PLoS One (2010) 1.26
Caspase-1 dependent IL-1β secretion is critical for host defense in a mouse model of Chlamydia pneumoniae lung infection. PLoS One (2011) 1.25
Immunomodulation of atherosclerosis: implications for vaccine development. Arterioscler Thromb Vasc Biol (2004) 1.23
The Pediatric Rheumatology European Society/American College of Rheumatology/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosis. Arthritis Rheum (2007) 1.23
TLR/MyD88 and liver X receptor alpha signaling pathways reciprocally control Chlamydia pneumoniae-induced acceleration of atherosclerosis. J Immunol (2008) 1.22
Systemic sclerosis in childhood: clinical and immunologic features of 153 patients in an international database. Arthritis Rheum (2006) 1.21
Adalimumab therapy for childhood uveitis. J Pediatr (2006) 1.20
Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis. Circulation (2004) 1.19
Narrative review: drug-eluting stents for the management of restenosis: a critical appraisal of the evidence. Ann Intern Med (2006) 1.19
Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences. Arterioscler Thromb Vasc Biol (2003) 1.19
Proinflammatory mediators upregulate snail in head and neck squamous cell carcinoma. Clin Cancer Res (2009) 1.17
Increased expression of membrane type 3-matrix metalloproteinase in human atherosclerotic plaque: role of activated macrophages and inflammatory cytokines. Circulation (2002) 1.16
Intramyocardial injection of allogenic bone marrow-derived mesenchymal stem cells without immunosuppression preserves cardiac function in a porcine model of myocardial infarction. J Cardiovasc Pharmacol Ther (2005) 1.15
Mastoparan, a G protein agonist peptide, differentially modulates TLR4- and TLR2-mediated signaling in human endothelial cells and murine macrophages. J Immunol (2005) 1.14
TLR2 and MyD88 contribute to Lactobacillus casei extract-induced focal coronary arteritis in a mouse model of Kawasaki disease. Circulation (2005) 1.14